Eton Pharmaceuticals, Inc.

NASDAQ:ETON

Biotechnology

Healthcare
$61.99 -1.39%

-$0.46 today

Market cap
$1.79B
Beta
0.89
P/E (TTM)
-597.6
EPS (TTM)
-$0.05
52W Low $13.09High $35.66

Volume 0.48M

Average 0.43M

Income Statement

Follow revenue through to earnings.

Revenue

$79.95M

FY 2025 · Annual

+104.9% YoY

Operating Income

$72,000.00

FY 2025 · Annual

Net Income

-$4.60M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue21.83M21.25M31.64M39.01M79.95M
Cost of Revenue2.62M6.93M10.58M15.6M37.21M
Gross Profit19.21M14.32M21.06M23.41M42.74M
Gross Margin88.0%67.4%66.6%60.0%53.5%
Research & Development6.24M4M3.32M3.26M7.77M
Selling, General & Admin14.47M18.58M18.93M22.75M35.82M
Operating Expenses20.7M22.58M22.25M26.01M42.67M
Depreciation & Amortization462K1.77M901K1.15M4.04M
EBITDA(1.49M)(7.25M)212K(657K)4.27M
EBITDA Margin-6.8%-34.1%0.7%-1.7%5.3%
Operating Income(1.5M)(8.26M)(1.19M)(2.6M)72K
Operating Margin-6.8%-38.9%-3.8%-6.7%0.1%
Interest Income00000
Interest Expense1.04M955K1.06M2.01M4.78M
Other Income / Expenses(460K)(761K)503K(1.21M)(4.63M)
Income Before Tax(1.96M)(9.02M)(689K)(3.81M)(4.56M)
Pre-Tax Margin-9.0%-42.4%-2.2%-9.8%-5.7%
Income Tax Expense00247K15K43K
Net Income(1.96M)(9.02M)(936K)(3.82M)(4.6M)
Net Margin-9.0%-42.4%-3.0%-9.8%-5.8%
EPS (Basic)(0.08)(0.36)(0.04)(0.15)(0.17)
EPS (Diluted)(0.08)(0.36)(0.04)(0.15)(0.17)
Weighted Avg Shares25.21M25.15M25.65M25.9M26.91M
Weighted Avg Shares (Diluted)25.21M25.15M25.65M25.9M26.91M

ETON Earnings Waterfall · TTM

NASDAQ:ETON · Revenue to Net Income

Key Ratios

EPS$-0.06
Gross Margin55.1%
Net Margin-2.2%
P/E Ratio18.0
P/S Ratio23.8

Analysis

$86.9M of revenue converted into -$1.5M of net income for the selected period. Gross margin is 55.1% and net margin is -2.2%, showing how much revenue survives after costs and taxes. EPS is $-0.06, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

How much revenue does ETON generate?

Eton Pharmaceuticals, Inc. (ETON) reported $79.95M of revenue in fiscal 2025.

Is ETON profitable?

Eton Pharmaceuticals, Inc. (ETON) reported -$4.60M of net income, with a net margin of -5.8%.